Faculty of 1000 evaluation for Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying?

Niki Karavitaki, Georgia Ntali
  • November 2015, Faculty of 1000, Ltd.
  • DOI: 10.3410/f.720334663.793511705

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication


The following have contributed to this page: GEORGIA NTALI

In partnership with: